Oral treatment with RU 41.740 (BiostimTM) in patients with advanced colorectal cancer: Influence on the blood lymphocyte population

This publication has 12 references indexed in Scilit:

• THE EFFECT OF RU 41.740, AN IMMUNE MODULATING COMPOUND, IN THE PREVENTION OF ACUTE EXACERBATIONS IN PATIENTS WITH CHRONIC-BRONCHITIS
  1986
• The effect of RU 41.740 (Biostim) on the production of interleukin-1 by monocytes and enriched large granular lymphocytes in normals and patients with hepatocellular carcinoma
  Cancer Immunology, Immunotherapy, 1986
• Influence of RU 41.740, a glycoprotein extract from Klebsiella pneumoniae, on the murine system. II. RU 41.740 facilitates the response to Con A in otherwise unresponsive T-enriched cells.
  The Journal of Immunology, 1985
• Immunoglobulin M and immunoglobulin G secretion by human B cells exposed to RU 41.740, a glycoprotein extract from Klebsiella pneumoniae
  Cellular Immunology, 1985
• Induction of interleukin 1 secretion by murine macrophages and human monocytes after stimulation by RU 41740, a bacterial immunomodulator
  International Journal of Immunopharmacology, 1985
• Influence of RU 41.740, a glycoprotein extract from Klebsiella pneumoniae, on the murine immune system. I. T-independent polyclonal B cell activation.
  The Journal of Immunology, 1984
• Immunological activities of RU-41740, a glycoproteic extract from klebsiella pneumoniae
  Annales de l'Institut Pasteur / Immunologie, 1984
• Conversion of skin tests in cancer patients after a short course of treatment with a new immunostimulating compound
  Cancer Immunology, Immunotherapy, 1980
• Characteristics of human mononuclear phagocytes
  Blood, 1979
• Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon
  International Journal of Cancer, 1978